HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jianfeng Zhou Selected Research

Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)

11/2022Excessive IL-10 and IL-18 trigger hemophagocytic lymphohistiocytosis-like hyperinflammation and enhanced myelopoiesis.
8/2022The superiority of Epstein-Barr virus DNA in plasma over in peripheral blood mononuclear cells for monitoring EBV-positive NK-cell lymphoproliferative diseases.
1/2020Salvage therapy with dose-escalating ruxolitinib as a bridge to allogeneic stem cell transplantation for refractory hemophagocytic lymphohistiocytosis.
1/2020Serum soluble VSIG4 as a surrogate marker for the diagnosis of lymphoma-associated hemophagocytic lymphohistiocytosis.
4/2016Search for the potential "second-hit" mechanism underlying the onset of familial hemophagocytic lymphohistiocytosis type 2 by whole-exome sequencing analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jianfeng Zhou Research Topics

Disease

130Neoplasms (Cancer)
11/2022 - 12/2004
31Ovarian Neoplasms (Ovarian Cancer)
10/2019 - 01/2004
23Neoplasm Metastasis (Metastasis)
10/2021 - 01/2005
22Leukemia
01/2022 - 01/2005
21Uterine Cervical Neoplasms (Cancer of the Cervix)
02/2020 - 09/2005
16Lymphoma (Lymphomas)
01/2022 - 01/2005
14Multiple Myeloma
01/2022 - 12/2010
13Hematologic Neoplasms (Hematological Malignancy)
06/2022 - 01/2004
12B-Cell Lymphoma (Lymphoma, B Cell)
01/2022 - 06/2012
12Infections
01/2022 - 02/2014
11Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 10/2011
10Carcinogenesis
01/2022 - 07/2005
10Carcinoma (Carcinomatosis)
08/2019 - 01/2004
9COVID-19
01/2022 - 01/2020
8Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
05/2022 - 08/2012
8Hemorrhage
02/2022 - 06/2016
8Colorectal Neoplasms (Colorectal Cancer)
10/2021 - 01/2018
8Breast Neoplasms (Breast Cancer)
01/2014 - 01/2006
6Disease Progression
01/2022 - 04/2008
6Hypoxia (Hypoxemia)
01/2021 - 02/2008
5Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
11/2022 - 04/2016
5Non-Hodgkin Lymphoma (Lymphosarcoma)
05/2022 - 01/2005
5Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2022 - 01/2018
5Prostatic Neoplasms (Prostate Cancer)
02/2015 - 06/2007
4Hodgkin Disease (Hodgkin's Disease)
01/2022 - 01/2019
4Residual Neoplasm
05/2021 - 09/2014
4Aplastic Anemia (Anemia, Hypoplastic)
02/2014 - 01/2004
4Lymphatic Metastasis
11/2010 - 03/2008
3Lymphopenia (Lymphocytopenia)
11/2022 - 01/2019
3Glioma (Gliomas)
01/2022 - 01/2016
3Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2022 - 01/2020
3Graft vs Host Disease (Graft-Versus-Host Disease)
01/2022 - 11/2015
3Cytokine Release Syndrome
01/2022 - 12/2020
3Neutropenia
01/2022 - 12/2015
3Virus Diseases (Viral Diseases)
10/2021 - 12/2009
3Hypertension (High Blood Pressure)
10/2021 - 01/2020
3Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2021 - 01/2015
3Hematologic Diseases (Blood Diseases)
09/2020 - 02/2011
3Femoral Neck Fractures
04/2020 - 01/2018
3Splenomegaly
01/2020 - 10/2015
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2018 - 01/2010
3Stomach Neoplasms (Stomach Cancer)
10/2017 - 01/2012
3Retinoblastoma (Glioblastoma, Retinal)
01/2015 - 08/2007
3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
12/2014 - 08/2012

Drug/Important Bio-Agent (IBA)

39Chimeric Antigen ReceptorsIBA
06/2022 - 01/2018
36Proteins (Proteins, Gene)FDA Link
12/2022 - 07/2004
15Biological ProductsIBA
01/2022 - 01/2007
13Cisplatin (Platino)FDA LinkGeneric
04/2014 - 07/2004
12CytokinesIBA
01/2022 - 01/2009
12Biomarkers (Surrogate Marker)IBA
01/2022 - 11/2010
9Messenger RNA (mRNA)IBA
12/2022 - 01/2004
9AntigensIBA
01/2022 - 03/2010
9Histone Deacetylase InhibitorsIBA
06/2017 - 09/2005
9Small Interfering RNA (siRNA)IBA
01/2017 - 02/2008
8bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
01/2022 - 10/2018
7Peptides (Polypeptides)IBA
02/2014 - 01/2006
6DNA (Deoxyribonucleic Acid)IBA
08/2022 - 10/2006
6zanubrutinibIBA
01/2022 - 01/2020
6VaccinesIBA
02/2020 - 09/2009
6trichostatin A (A 300)IBA
06/2017 - 09/2005
6theasinensin AIBA
06/2017 - 09/2005
6Phosphotransferases (Kinase)IBA
04/2016 - 01/2005
5Pharmaceutical PreparationsIBA
11/2022 - 04/2005
5Agammaglobulinaemia Tyrosine KinaseIBA
01/2022 - 01/2020
5EnzymesIBA
01/2020 - 02/2006
5SurvivinIBA
08/2019 - 07/2005
5Complementary DNA (cDNA)IBA
11/2011 - 12/2005
4Monoclonal AntibodiesIBA
02/2022 - 06/2012
4AcidsIBA
01/2022 - 09/2008
4Transcription Factors (Transcription Factor)IBA
10/2021 - 10/2003
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2021 - 04/2006
4Ferritins (Ferritin)IBA
07/2020 - 10/2015
4ElementsIBA
04/2020 - 01/2018
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020 - 02/2014
4Caspase 3 (Caspase-3)IBA
01/2011 - 07/2004
4Aromatase (CYP19)IBA
02/2006 - 05/2002
3RNA (Ribonucleic Acid)IBA
01/2022 - 06/2010
3B-Cell Maturation AntigenIBA
12/2021 - 10/2018
3N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamideIBA
10/2021 - 01/2017
3Circulating Tumor DNAIBA
05/2021 - 01/2019
3Antineoplastic Agents (Antineoplastics)IBA
01/2021 - 09/2008
3HMPL-013IBA
01/2021 - 01/2018
3InterleukinsIBA
01/2020 - 06/2011
3Interleukin-6 (Interleukin 6)IBA
01/2020 - 12/2013
3UbiquitinIBA
11/2019 - 01/2013
3Fluorouracil (Carac)FDA LinkGeneric
08/2019 - 01/2010
3PlatinumIBA
10/2018 - 11/2013
3Thymidine KinaseIBA
01/2018 - 10/2007
3Bortezomib (Velcade)FDA Link
06/2017 - 05/2011
3TOR Serine-Threonine KinasesIBA
12/2014 - 10/2011
3Fibronectins (Fibronectin)IBA
08/2013 - 07/2007
3OligonucleotidesIBA
01/2012 - 12/2004

Therapy/Procedure

77Therapeutics
11/2022 - 01/2006
22Drug Therapy (Chemotherapy)
01/2022 - 07/2004
21Immunotherapy
01/2022 - 06/2007
10Stem Cell Transplantation
01/2022 - 01/2015
7Transplantation
01/2022 - 05/2013
7Hematopoietic Stem Cell Transplantation
01/2022 - 01/2004
5Radiotherapy
01/2022 - 11/2008
3Heterologous Transplantation (Xenotransplantation)
01/2013 - 08/2012